Adrian Peirce

Finance Director

Professional Overview
Adrian Peirce is a seasoned Finance Director with extensive experience in the pharmaceutical industry. He currently leads the finance function at Johnson & Johnson, driving strategic decision-making and ensuring financial stability and growth across the organization.

Experience Summary

Current Role
As the Finance Director at Johnson & Johnson, Adrian oversees all financial operations, including budgeting, forecasting, reporting, and risk management. He has been instrumental in implementing robust financial controls and streamlining processes, leading to a 15% reduction in operating costs over the past 3 years. Under his leadership, the finance team has consistently exceeded revenue targets, contributing to the company's strong market performance.

Career Progression
Prior to his current role, Adrian held various finance leadership positions at leading pharmaceutical companies, including a 7-year tenure as the Finance Manager at GlaxoSmithKline. In this role, he played a key part in the successful integration of two major acquisitions, driving synergies and optimizing financial workflows. Earlier in his career, Adrian worked as a Financial Analyst at Pfizer, where he honed his skills in financial modeling and data analysis.

Academic Background
Adrian holds a Bachelor of Science degree in Accounting from the University of Reading and is a Chartered Financial Analyst (CFA). He has also completed executive leadership programs at the London Business School, further strengthening his strategic decision-making and change management capabilities.

Areas of Expertise

• Financial planning and analysis

• Financial reporting and control

• Mergers and acquisitions

• Risk management and compliance

• Process optimization and automation

• Cross-functional collaboration and leadership

Professional Impact
During his tenure at Johnson & Johnson, Adrian has led the implementation of a new enterprise resource planning (ERP) system, resulting in a 20% improvement in data accuracy and a 30% reduction in month-end close times. He has also spearheaded the development of a data-driven financial forecasting model, enabling the organization to make more informed strategic decisions.

Adrian's contributions extend beyond the finance function, as he actively participates in industry forums and provides thought leadership on emerging trends and best practices in pharmaceutical finance. He is a regular speaker at industry events and has authored several published articles on financial transformation in the life sciences sector.

Conclusion
With his proven track record of financial leadership, strategic vision, and operational excellence, Adrian Peirce is a valuable asset to Johnson & Johnson. His commitment to driving innovation and continuous improvement within the finance function positions him as a trusted advisor and strategic partner to the broader organization.